Henry Schein, Inc. (VIE:HSIC)
Austria · Delayed Price · Currency is EUR | Market Cap | 8.42B +23.2% |
| Revenue (ttm) | 11.93B +6.5% |
| Net Income | 353.35M +3.6% |
| EPS | 3.01 +10.3% |
| Shares Out | n/a |
| PE Ratio | 23.84 |
| Forward PE | 14.52 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 75.00 |
| Previous Close | 75.00 |
| Day's Range | 74.00 - 75.00 |
| 52-Week Range | 52.30 - 80.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 5, 2026 |
About Henry Schein
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, di... [Read more]
Financial Performance
In 2025, Henry Schein's revenue was $13.18 billion, an increase of 4.03% compared to the previous year's $12.67 billion. Earnings were $398.00 million, an increase of 2.05%.
Financial numbers in USD Financial StatementsNews
Henry Schein Announces Chief Financial Officer Leadership Transition
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) announced today that Emmanuel Caprais, former Senior Vice President and Chief Financial Officer of ITT, Inc. (NYSE: ITT), has been na...
Henry Schein Cares Marks 25 Years of Helping Health Happen®
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Cares, Henry Schein, Inc.'s global corporate citizenship program, is celebrating a quarter century of bringing together Team Schein Members, customers, su...
Henry Schein Transcript: 2026 Global Healthcare Conference
Leadership outlined priorities of accelerating growth, simplifying operations, and increasing rigor, with a $200 million operating income improvement plan and double-digit EPS growth targeted. Dental and medical segments are growing, with strong performance in consumables, private label, and technology. Capital allocation favors disciplined M&A and share buybacks.
Applied BioCode Announces Distribution Agreement with Henry Schein
SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)-- #ClinicalDiagnostics--Applied BioCode today announced a distribution agreement with Henry Schein, a leading provider of healthcare products and services, to...
Henry Schein to Participate in Upcoming Investor Conference in September
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that the Company will presen...
Henry Schein Earnings Call Transcript: Q2 2026
Q2 2026 saw strong sales and margin growth, with internal local currency sales up 4.6% and non-GAAP EPS up 15.5%. Full-year guidance was raised, driven by robust performance across dental, medical, and technology segments, and value creation initiatives remain on track.
Henry Schein Earnings release: Q2 2026
Henry Schein released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
Henry Schein Slides: Q2 2026
Henry Schein has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 4, 2026.
Henry Schein Quarterly report: Q2 2026
Henry Schein has published its Q2 2026 quarterly earnings report on August 4, 2026.
Henry Schein Slides: Corporate presentation
Henry Schein has posted slides in relation to its latest quarterly earnings report, which was published on August 4, 2026.
Henry Schein Reports Strong Second Quarter 2026 Financial Results and Raises FY2026 Guidance
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, today reported financial resu...
Henry Schein Announces Leadership Transitions
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) announced today that it is creating the Henry Schein Leadership Team (HSLT) to replace its Executive Management Committee. The Compan...
Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 a.m. ET
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will ...
GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide
MIAMI, June 30, 2026 /PRNewswire/ -- GoTu Technology, the nation's leading dental talent marketplace, and Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to of...
Henry Schein Transcript: Stifel Jaws & Paws Conference 2026
Leadership is driving transformation through simplification, technology, and value creation, with steady dental and improving medical markets. Accelerated innovation, price optimization, and disciplined capital allocation support growth, with expectations for stronger earnings in the second half and double-digit EPS growth potential by 2027.
Henry Schein Announces the Election of William K. “Dan” Daniel as Independent Chairman of the Board
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Boa...
Henry Schein Transcript: AGM 2026
The meeting featured leadership transitions, approval of all board and executive proposals, and adoption of a shareholder initiative to eliminate supermajority voting. Strategic focus remains on integrated healthcare solutions and digital innovation.
Henry Schein One Releases 2026 Catalyst Index, Revealing Clinical Performance as the Primary Driver of Growth
AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One, the global leader in dental technology, today announced the release of its 2026 Catalyst Index, the fifth edition of its annual benchmarking rep...
Henry Schein Transcript: Bank of America Global Healthcare Conference 2026
Q1 saw strong growth in dental, technology, and distribution, with margin expansion and reaffirmed value creation targets. DSOs and home solutions are key growth drivers, while ongoing initiatives in AI, pricing, and operational efficiency support a positive outlook for 2026.
Henry Schein Proxy statement: Proxy filing
Henry Schein filed a proxy statement on May 12, 2026, providing details for shareholder voting and corporate governance matters.
Henry Schein Earnings Call Transcript: Q1 2026
Q1 2026 saw 6.3% sales growth, margin expansion, and strong U.S. Dental and Global Technology performance, offsetting medical softness. Guidance for 2026 remains unchanged, with high-margin businesses nearing 50% of operating income and value creation initiatives driving future growth.
Henry Schein Earnings release: Q1 2026
Henry Schein released its Q1 2026 earnings on May 5, 2026, summarizing the period's financial results.
Henry Schein Slides: Q1 2026
Henry Schein has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 5, 2026.
Henry Schein Quarterly report: Q1 2026
Henry Schein has published its Q1 2026 quarterly earnings report on May 5, 2026.
Henry Schein reaffirms annual profit forecast, beats Q1 estimates on dental strength
Henry Schein on Tuesday reaffirmed its annual forecast after beating Wall Street expectations for first-quarter profit as the medical supplies distributor saw strong demand across its dental business...